Get all your news in one place.
100's of premium titles.
One app.
Start reading
Caixin Global
Caixin Global
Business
Hua Ang, Wang Han and Denise Jia

Fosun Reports $157 Million of China mRNA Vaccine Sales in 2021

What’s new: Sales of a Chinese version of Pfizer-BioNTech’s Covid-19 mRNA vaccine exceeded 1 billion yuan ($157 million) in 2021, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (600196.SH) disclosed Wednesday in its annual report.

Fosun is the exclusive partner of Germany’s BioNTech for marketing in Greater China the mRNA vaccine it co-developed with U.S. drug giant Pfizer Inc.. Known in China as the Comirnaty vaccine, the product hasn’t been approved for the Chinese mainland and is sold only in Hong Kong, Macao and Taiwan.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.